Total Payments
$13,545
2024 Payments
$469.95
Companies
17
Transactions
64
Medicare Patients
1,470
Medicare Billing
$231,558
Payment Breakdown by Category
Other$7,228 (53.4%)
Food & Beverage$3,684 (27.2%)
Travel$2,013 (14.9%)
Consulting$620.00 (4.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,228 | 9 | 53.4% |
| Food and Beverage | $3,684 | 50 | 27.2% |
| Travel and Lodging | $2,013 | 4 | 14.9% |
| Consulting Fee | $620.00 | 1 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $9,417 | 23 | $0 (2023) |
| Ipsen Pharma SAS | $1,229 | 2 | $0 (2022) |
| Grifols USA, LLC | $815.45 | 3 | $0 (2023) |
| ABBVIE INC. | $469.95 | 12 | $0 (2024) |
| ARGENX US, INC. | $334.31 | 4 | $0 (2024) |
| UCB, Inc. | $255.42 | 2 | $0 (2023) |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $203.94 | 4 | $0 (2024) |
| Grifols Shared Services North America, Inc. | $129.28 | 1 | $0 (2024) |
| GENZYME CORPORATION | $126.47 | 3 | $0 (2018) |
| EMD Serono, Inc. | $125.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $469.95 | 10 | ARGENX US, INC. ($230.59) |
| 2023 | $1,067 | 13 | ABBVIE INC. ($300.25) |
| 2022 | $7,320 | 16 | Alexion Pharmaceuticals, Inc. ($5,726) |
| 2021 | $1,437 | 8 | Alexion Pharmaceuticals, Inc. ($1,265) |
| 2020 | $2,087 | 4 | Alexion Pharmaceuticals, Inc. ($2,087) |
| 2019 | $929.76 | 8 | Grifols USA, LLC ($645.57) |
| 2018 | $218.54 | 4 | GENZYME CORPORATION ($111.13) |
| 2017 | $15.34 | 1 | GENZYME CORPORATION ($15.34) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/28/2024 | Kedrion Biopharma, Inc. | Albuked (Biological), KOATE, GAMMAKED | Food and Beverage | Cash or cash equivalent | $15.46 | General |
| Category: Critical Care | ||||||
| 09/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/24/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug), VYVGART | Food and Beverage | In-kind items and services | $109.57 | General |
| Category: Neurology | ||||||
| 09/05/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $98.85 | General |
| Category: Neurology | ||||||
| 08/19/2024 | Kedrion Biopharma, Inc. | Albuked (Biological), KOATE, GAMMAKED | Food and Beverage | Cash or cash equivalent | $24.71 | General |
| Category: Critical Care | ||||||
| 08/16/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Neurology | ||||||
| 07/16/2024 | Grifols Shared Services North America, Inc. | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $129.28 | General |
| Category: Immunology and Neurology | ||||||
| 07/10/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 05/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/12/2023 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $105.77 | General |
| 12/08/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/07/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $131.88 | General |
| Category: Rare Disease | ||||||
| 11/01/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2023 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $169.88 | General |
| Category: Immunology and Neurology | ||||||
| 10/20/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/27/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $120.42 | General |
| 09/25/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/20/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $123.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $135.00 | General |
| 08/18/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/10/2023 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $103.72 | General |
| Category: Immunology | ||||||
| 11/02/2022 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $119.81 | General |
| Category: Genetic Disease | ||||||
| 08/09/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $620.00 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 411 | 14,894 | $437,475 | $104,061 |
| 2022 | 12 | 381 | 6,240 | $259,662 | $62,481 |
| 2021 | 11 | 380 | 446 | $146,530 | $35,261 |
| 2020 | 10 | 298 | 393 | $127,566 | $29,755 |
Total Patients
1,470
Total Services
21,973
Medicare Billing
$231,558
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 25 | 14,400 | $273,600 | $64,766 | 23.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 73 | $35,613 | $8,814 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 90 | 130 | $37,346 | $8,777 | 23.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 60 | 75 | $28,050 | $7,303 | 26.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 31 | 31 | $16,089 | $3,464 | 21.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 57 | $10,911 | $2,205 | 20.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $9,168 | $2,150 | 23.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 24 | 27 | $7,506 | $2,002 | 26.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 14 | 14 | $8,470 | $1,960 | 23.1% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 12 | 27 | $5,940 | $1,486 | 25.0% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 13 | 15 | $2,640 | $667.08 | 25.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 21 | $2,142 | $465.46 | 21.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 14 | 5,790 | $109,610 | $26,684 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 91 | 136 | $40,084 | $9,449 | 23.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 47 | 61 | $29,653 | $7,143 | 24.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 36 | 36 | $19,612 | $4,626 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $11,819 | $2,655 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 60 | $12,032 | $2,636 | 21.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 26 | $10,036 | $2,491 | 24.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 19 | 19 | $9,758 | $2,466 | 25.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 24 | 25 | $6,806 | $1,762 | 25.9% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 24 | 28 | $4,683 | $1,240 | 26.5% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 11 | 11 | $4,170 | $1,004 | 24.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 16 | 19 | $1,399 | $324.38 | 23.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 81 | 117 | $36,217 | $8,008 | 22.1% |
About Dr. Anne Hatch, DO
Dr. Anne Hatch, DO is a Neurology healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2014. The National Provider Identifier (NPI) number assigned to this provider is 1457766792.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anne Hatch, DO has received a total of $13,545 in payments from pharmaceutical and medical device companies, with $469.95 received in 2024. These payments were reported across 64 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($7,228).
As a Medicare-enrolled provider, Hatch has provided services to 1,470 Medicare beneficiaries, totaling 21,973 services with total Medicare billing of $231,558. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Phoenix, AZ
- Active Since 06/25/2014
- Last Updated 07/10/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457766792
Products in Payments
- SOLIRIS (Biological) $4,489
- Soliris (Drug) $3,352
- ULTOMIRIS (Biological) $1,369
- DYSPORT (Drug) $1,229
- Gamunex-C (Biological) $944.73
- VYVGART HYTRULO (Drug) $230.59
- BOTOX (Biological) $224.09
- AUBAGIO (Drug) $126.47
- Mavenclad (Drug) $125.00
- QULIPTA (Drug) $123.80
- Radicava (Drug) $120.25
- ONPATTRO (Drug) $119.81
- VYVGART (Drug) $103.72
- SOLIRIS (Drug) $100.30
- Duopa (Drug) $95.41
- SPINRAZA (Biological) $93.16
- RADICAVA (Drug) $83.69
- Tiglutik (Drug) $73.41
- NUPLAZID (Drug) $64.03
- Albuked (Biological) $40.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Phoenix
Barry Hendin, Md, MD
Neurology — Payments: $3.0M
Neurology $3.0M
Maria Ospina, Md, MD
Neurology — Payments: $1.7M
Neurology $1.7M
Dr. Suraj Muley, Md, MD
Neurology — Payments: $1.5M
Neurology $1.5M
Steve Chung, M.d, M.D
Neurology — Payments: $993,222
Neurology $993,222
Shafeeq Ladha, M.d, M.D
Neurology — Payments: $712,796
Neurology $712,796
Lori Travis, Md, MD
Neurology — Payments: $705,788
Neurology $705,788